Although these results are preliminary and the numbers of patients included with NET G3 were limited, they support further investigation into neoadjuvant strategies, particularly for locally advanced tumours and tumours with high‐risk features (e.g., elevated Ki‐67). Here, MKI67 is linked to neoplasm.